STTK Q3 2021 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$284M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-22.0% YoY

Gross Profit

-$13M-696.7% margin

Operating Income

-$18M-925.3% margin

Net Income

-$17M-916.3% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+144.9%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$311M

Total Liabilities

$49M

Stockholders' Equity

$261M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-22.0%
Gross Profit	-$13M	-$9M	-41.3%
Operating Income	-$18M	-$12M	-48.5%
Net Income	-$17M	-$12M	-47.2%